Page 228 - Read Online
P. 228

Page 20 of 20                 dos Santos et al. J Cancer Metastasis Treat 2019;5:25  I  http://dx.doi.org/10.20517/2394-4722.2018.83

               113.  Schweitzer VG. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers
                   Surg Med 2001;29:305-13.
               114.  Stoodley M, Sikorski JM. Objective and useful mobility assessment of patients with arthropathy of the hip and knee. Clin Orthop Relat Res
                   1987;1:110-6.
               115.  Lou PJ, Jäger HR, Jones L, Theodossy T, Bown SG, et al. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck
                   cancer. Br J Cancer 2004;91:441-6.
               116.  Story W, Sultan AA, Bottini G, Vaz F, Lee G, et al. Strategies of airway management for head and neck photo-dynamic therapy. Lasers Surg
                   Med 2013;45:370-6.
               117.  Bown SG, Rogowska AZ, Whitelaw DE, Lees WR, Lovat LB, et al. Photodynamic therapy for cancer of the pancreas. Gut 2002;50:549-57.
               118.  Pereira SP, Ayaru L, Rogowska A, Mosse A, Hatfield ARW, et al. Photodynamic therapy of malignant biliary strictures using meso-
                   tetrahydroxyphenylchlorin. Eur J Gastroenterol Hepatol 2007;19:479-85.
               119.  Wyss P, Schwarz V, Dobler-Girdziunaite D, Hornung R, Walt H, et al. Photodynamic therapy of locoregional breast cancer recurrences
                   using a chlorin-type photosensitizer. Int J cancer 2001;93:720-4.
               120.  Moore CM, Nathan TR, Lees WR, Mosse CA, Freeman A, et al. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC)
                   in early prostate cancer. Lasers Surg Med 2006;38:356-63.
               121.  Nathan TR, Whitelaw DE, Chang SC, Lees WR, Ripley PM, et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy:
                   a phase I study. J Urol 2002;168:1427-32.
               122.  Baskaran R, Lee J, Yang SG. Clinical development of photodynamic agents and therapeutic applications. Biomater Res 2018;22:25.
               123.  Cuenca RE, Allison RR, Sibata C, Downie GH. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg
                   Oncol 2004;11:322-7.
               124.  Taber SW, Fingar VH, Coots CaT, Wieman TJ. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of
                   cutaneous disease: a phase I clinical study. Clin Cancer Res 1998;4:2741-6.
               125.  Li X, Ferrel GL, Guerra MC, Hode T, Lunn JA, et al. Preliminary safety and efficacy results of laser immunotherapy for the treatment of
                   metastatic breast cancer patients. Photochem Photobiol Sci 2011;10:817-21.
               126.  Mfouo-Tynga I, Houreld NN, Abrahamse H. Evaluation of cell damage induced by irradiated Zinc-Phthalocyanine-gold dendrimeric
                   nanoparticles in a breast cancer cell line. Biomed J 2018;41:254-64.
               127.  Yang Y, Yang X, Li H, Li C, Ding H, et al. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for
                   synergistic breast tumor therapy. Colloids Surfaces B Biointerfaces 2019;173:564-70.
               128.  Xu W, Qian J, Hou G, Wang Y, Wang J, et al. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for
                   photodynamic/photothermal therapy of breast cancer. Acta Biomater 2018;83:400-13.
               129.  Damke GMZF, Souza RP, Montanha MC, Damke E, Gonçalves RS, et al. Selective photodynamic effects on breast cancer cells provided by
                   P123 Pluronic®-based nanoparticles modulating hypericin delivery. Anticancer Agents Med Chem 2018; doi: 10.2174/18715206186661811
                   02091010.
               130.  Hodgkinson N, Kruger CA, Abrahamse H. Targeted photodynamic therapy as potential treatment modality for the eradication of colon
                   cancer and colon cancer stem cells. Tumour Biol 2017;39:1010428317734691.
               131.  Theodossiou TA, Gonçalves AR, Yannakopoulou K, Skarpen E, Berg K. Photochemical internalization of tamoxifens transported by a
                   “Trojan-horse” nanoconjugate into breast-cancer cell lines. Angew Chem Int Ed Engl 2015;54:4885-9.
               132.  Eng MS, Kaur J, Prasmickaite L, Engesæter BØ, Weyergang A, et al. Enhanced targeting of triple-negative breast carcinoma and malignant
                   melanoma by photochemical internalization of CSPG4-targeting immunotoxins. Photochem Photobiol Sci 2018;17:539-51.
               133.  Norum O, Kristian P, Weyergang A, Giercksky K, Berg K. Photochemical internalization (PCI ) in cancer therapy: from bench towards
                   bedside medicine. J Photochem Photobiol B Biol 2009;96:83-92.
               134.  Olsen CE, Weyergang A, Edwards VT, Berg K, Brech A, et al. Development of resistance to photodynamic therapy (PDT) in human breast
                   cancer cells is photosensitizer-dependent: possible mechanisms and approaches for overcoming PDT-resistance. Biochem Pharmacol
                   2017;144:63-77.
               135.  Broekgaarden M, Weijer R, van Gulik TM, Hamblin MR, Heger M. Tumor cell survival pathways activated by photodynamic therapy: a
                   molecular basis for pharmacological inhibition strategies. Cancer Metastasis Rev 2015;34:643-90.
               136.  Sneider A, Jadia R, Piel B, VanDyke D, Tsiros C, et al. Engineering remotely triggered liposomes to target triple negative breast cancer.
                   Oncomedicine 2017;2:1-13.
   223   224   225   226   227   228   229   230   231   232   233